Biological influence of brain-derived neurotrophic factor (BDNF) on colon cancer cells

Experimental and Therapeutic Medicine

Volumn 6, Issue 6, 2013, Pages 1475-1481

  Yang, Xiaomei ^a,b   Martin, Tracey A ^a,b   Jiang, Wen Guo ^a,b  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; BDNF; Colon cancer; Proliferation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER STAGING; CELL FUNCTION; CELL GROWTH; CELL LINE; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; FLOW CYTOMETRY; GENE SILENCING; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBOZYME VECTOR; RNA EXTRACTION;

EID: 84888411673     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1330     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin: 56: 106-130, 2006.
2. Zhang J, Dhaka, IB, Zhao Z and Li L: Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: role of nutrition transition. Eur J Cancer Prev 21: 480-489, 2012
3. Foretova L, Petrakova K, Palacova M, Kalabova R, Svoboda M, Navratilova M, Schneiderova M, Bolcak K, Krejci E, Drazan L, Mikova M, Hazova J, Vasickova P and Machackova E: Genetic testing and prevention of hereditary cancer at the MMCI-over 10 years of experience. Klin Onkol 23: 388-400, 2012.
4. Glück S and Mamounas T: Improving outcomes in early-stage breast cancer. Oncology (Williston Park) 24 (Suppl 4): 1-15, 2010.
5. Brunetto de Farias C, Rosemberg DB, Heinen TE, Koehler-Santos P, Abujamra AL, Kapczinski F, Brunetto AL, Ashton-Prolla P, Meurer L, Reis Bogo M, Damin DC, Schwartsmann G and Roesler R: BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer. Oncology 79: 430-439, 2010.
6. Barde YA, Edgar D and Thoenen H: Purification of a new neurotrophic factor from mammalian brain. EMBO J 1: 549-553, 1982.
7. Numakawa T, Suzuki S, Kumamaru E, Adachi N, Richards M and Kunugi H: BDNF function and intracellular signaling in neurons. Histol Histopathol 25: 237-258, 2010.
8. Huang YT, Lai PC, Wu CC, Hsu SH, Cheng CC, Lan YF and Chiu TH: BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells. Int J Oncol 36: 1469-1476, 2010.
9. Sun CY, Hu Y, Huang J, Chu ZB, Zhang L, She XM and Chen L: Brain-derived neurotrophic factor induces proliferation, migration, and VEGF secretion in human multiple myeloma cells via activation of MEK-ERK and PI3K/AKT signaling. Tumour Biol 31: 121-128, 2010.
10. Zhang L, Hu Y, Sun CY, Huang J and Chu ZB: Brain-derived neurotrophic factor promotes the secretion of MMP-9 in human myeloma cell through modulation of nucleus factor-kappaB. Zhonghua Xue Ye Xue Za Zhi 29: 243-246, 2008 (In Chinese).
11. Zhang S, Guo D, Luo W, Zhang Q, Zhang Y, Li C, Lu Y, Cui Z and Qiu X: TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells. BMC Cancer 10: 43, 2010.
12. Akil H, Perraud A, Mélin C, Jauberteau MO and Mathonnet M: Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival. PLoS One 6: e25097, 2011.
13. Festuccia C, Gravina GL, Millimaggi D, Muzi P, Speca S, Ricevuto E, Vicentini C and Bologna M: Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells. Oncol Rep 18: 503-511, 2007.
14. Li Z, Zhang J, Liu Z, Woo CW and Thiele CJ: Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death. Cell Death Differ 14: 318-326, 2007.
15. Patani N, Jiang WG and Mokbel K: Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer. Cancer Cell Int 11: 23, 2011.
16. Guo D, Hou X, Zhang H, Sun W, Zhu L, Liang J and Jiang X: More expressions of BDNF and TrkB in multiple hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis, supressed invasion of HepG2 and HCCLM3 cells. J Exp Clin Cancer Res 30: 97, 2011.
17. Kawamura N, Kawamura K, Manabe M and Tanaka T: Inhibition of brain-derived neurotrophic factor/tyrosine kinase B signaling suppresses choriocarcinoma cell growth. Endocrinology 151: 3006-3014, 2010.
18. Li Z and Thiele CJ: Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway. Expert Opin Ther Targets 11: 1611-1621, 2007.
19. Sheikh AM, Malik M, Wen G, Chauhan A, Chauhan V, Gong CX, Liu F, Brown WT and Li X: BDNF-Akt-Bcl2 antiapoptotic signaling pathway is compromised in the brain of autistic subjects. J Neurosci Res 88: 2641-2647, 2010.
20. Yu X, Liu L, Cai B, He Y and Wan X: Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer. Cancer Sci 99: 543-552, 2008.